WEST PHARMACEUTICAL SERVICES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period of 94.22 thousand shares for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-06.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod · last filed 2015-05-06
- WEST PHARMACEUTICAL SERVICES, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2015-03-31 was 94.22K shares, a 26.80% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2014-09-30 was 3.34K shares, a 96.23% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2014-06-30 was 1.78K shares, a 8.56% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2014-03-31 was 128.71K shares, a 48.22% increase year-over-year.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 9 month |
|---|---|---|---|
| 2015-03-31 | 94.22K shares 10-Q · filed 2015-05-06 | ||
| 2014-09-30 | 3.34K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-03 | 5.11K shares derived: sum of 2 quarters · filed 2014-11-03 | 133.82K shares 10-Q · filed 2014-11-03 |
| 2014-06-30 | 1.78K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | 130.49K shares 10-Q · filed 2014-08-01 | |
| 2014-03-31 | 128.71K shares 10-Q · filed 2014-05-08 | ||
| 2013-09-30 | 88.48K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-04 | 90.11K shares derived: sum of 2 quarters · filed 2013-11-04 | 176.95K shares 10-Q · filed 2013-11-04 |
| 2013-06-30 | 1.64K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-05 | 88.48K shares 10-Q · filed 2013-08-05 | |
| 2013-03-31 | 86.84K shares 10-Q · filed 2013-05-06 | ||
| 2012-03-31 | 101.86K shares 10-Q · filed 2012-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |